
### [NCIT:C4637](http://purl.obolibrary.org/obo/NCIT_C4637)
**Label:** Intestinal Neuroendocrine Tumor G1

**Subclasses:** [NCIT:C5547](http://purl.obolibrary.org/obo/NCIT_C5547) (Rectal Neuroendocrine Tumor G1), [NCIT:C6428](http://purl.obolibrary.org/obo/NCIT_C6428) (Descending Colon Neuroendocrine Tumor G1), [NCIT:C6427](http://purl.obolibrary.org/obo/NCIT_C6427) (Ascending Colon Neuroendocrine Tumor G1), [NCIT:C6424](http://purl.obolibrary.org/obo/NCIT_C6424) (Meckel Diverticulum Neuroendocrine Tumor G1), [NCIT:C6426](http://purl.obolibrary.org/obo/NCIT_C6426) (Transverse Colon Neuroendocrine Tumor G1), [NCIT:C5501](http://purl.obolibrary.org/obo/NCIT_C5501) (Cecum Neuroendocrine Tumor G1), [NCIT:C6425](http://purl.obolibrary.org/obo/NCIT_C6425) (Duodenal Neuroendocrine Tumor G1), [NCIT:C5497](http://purl.obolibrary.org/obo/NCIT_C5497) (Colon Neuroendocrine Tumor G1), [NCIT:C4638](http://purl.obolibrary.org/obo/NCIT_C4638) (Small Intestinal Neuroendocrine Tumor G1), [NCIT:C96160](http://purl.obolibrary.org/obo/NCIT_C96160) (Colorectal Neuroendocrine Tumor G1), 

**Class expressions from DL-Learner:**

- Thing 53.92%
- [NCIT:C60707](http://purl.obolibrary.org/obo/NCIT_C60707) (Neuron-Specific Enolase Positive Neoplastic Cells Present) 52.08%
- [NCIT:C60674](http://purl.obolibrary.org/obo/NCIT_C60674) (Chromogranin A Positive Neoplastic Cells Present) 52.08%
- [NCIT:C36133](http://purl.obolibrary.org/obo/NCIT_C36133) (Well Differentiated Lesion) 52.08%
- [NCIT:C36132](http://purl.obolibrary.org/obo/NCIT_C36132) (Poorly Differentiated Lesion) 52.08%
- [NCIT:C36130](http://purl.obolibrary.org/obo/NCIT_C36130) (Low Grade Lesion) 52.08%
- [NCIT:C35961](http://purl.obolibrary.org/obo/NCIT_C35961) (Low Mitotic Activity) 52.08%
- [NCIT:C28077](http://purl.obolibrary.org/obo/NCIT_C28077) (Grade 1) 52.08%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) 37.44%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 37.44%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 37.44%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 37.44%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 37.44%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 37.44%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 37.44%


